Cleared Traditional

K023222 - ISOCARE ONE STEP SPERM PROCESSING MEDIUM CAT# 2207-12

K023222 is an FDA 510(k) clearance for ISOCARE ONE STEP SPERM PROCESSING MEDIU..., manufactured by Invitrocare, Inc.. The device is a Class 2 Obstetrics & Gynecology device with product code MQL cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K023222 · Invitrocare, Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2002
Decision
90d
Days
Class 2
Risk

K023222 is an FDA 510(k) clearance for the ISOCARE ONE STEP SPERM PROCESSING MEDIUM CAT# 2207-12. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Invitrocare, Inc. (Frederick, US). The FDA issued a Cleared decision on December 26, 2002 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Invitrocare, Inc. devices

FDA 510(k) Submission Details - K023222

510(k) Number K023222 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2002
Decision Date December 26, 2002
Days to Decision 90 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 160d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQL Device Classification - Class 2, Special Controls

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 198
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K023222.
SYNVITRO HYADASE
K031228 · Medicult A/S · Jun 2003
EMBRYOGLUE
K031015 · Vitrolife Sweden AB · Jun 2003
SYDNEY IVF EMBRYO BIOPSY MEDIUM
K023850 · Cook Ob/Gyn · Jan 2003
SYDNEY IVF HYALURONIDASE
K023353 · Cook Urological, Inc. · Dec 2002
SPERMGRAD, MODELS 10022/10063
K023403 · Vitrolife Sweden AB · Dec 2002
ALLGRAD WASH (HERPES BUFFERED WASHING MEDIUM)
K023033 · Intl., Inc. · Nov 2002